5-methylcytosine has been researched along with Genito-urinary Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ci, W; Huang, C; Qi, J; Shi, Y; Tan, Y; Wang, J; Zhang, J; Zhang, Q | 1 |
| Bezerra, SM; Chaux, A; Gonzalez Roibon, N; Haffner, MC; Karram, S; Munari, E; Nelson, WG; Netto, GJ; Taheri, D; Vaghasia, AM; Yegnasubramanian, S | 1 |
2 other study(ies) available for 5-methylcytosine and Genito-urinary Cancer
| Article | Year |
|---|---|
Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways.
Topics: 5-Methylcytosine; Ascorbic Acid; Carcinogenesis; DNA; DNA Methylation; Fibrin; Humans; Magnesium; Male; Phosphates; Prostatic Neoplasms; Urogenital Neoplasms | 2022 |
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Cytosine; DNA Methylation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Urogenital Neoplasms | 2016 |